Transmembrane domain oligomerization propensity determined by ToxR assay.
about
Repositioning antimicrobial agent pentamidine as a disruptor of the lateral interactions of transmembrane domain 5 of EBV latent membrane protein 1.Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerizationTargeting the lateral interactions of transmembrane domain 5 of Epstein-Barr virus latent membrane protein 1Fusion Reporter Approaches to Monitoring Transmembrane Helix Interactions in Bacterial Membranes.
P2860
Transmembrane domain oligomerization propensity determined by ToxR assay.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transmembrane domain oligomerization propensity determined by ToxR assay.
@ast
Transmembrane domain oligomerization propensity determined by ToxR assay.
@en
type
label
Transmembrane domain oligomerization propensity determined by ToxR assay.
@ast
Transmembrane domain oligomerization propensity determined by ToxR assay.
@en
prefLabel
Transmembrane domain oligomerization propensity determined by ToxR assay.
@ast
Transmembrane domain oligomerization propensity determined by ToxR assay.
@en
P2093
P2860
P356
P1476
Transmembrane domain oligomerization propensity determined by ToxR assay.
@en
P2093
Alyssa Wiener
Catherine Joce
P2860
P356
10.3791/2721
P577
2011-05-26T00:00:00Z